IPP Bureau
GMM Pfaudler Q1FY23 consolidated PAT surges to Rs. 44.51 Cr
By IPP Bureau - July 29, 2022
GMM Pfaudler has reported total income of Rs. 767.73 crores during the period ended June 30, 2022
Biocon Q1FY23 consolidated PAT falls QoQ at Rs. 144.4 Cr
By IPP Bureau - July 28, 2022
Biocon has reported total income of Rs. 2217.4 crores during the period ended June 30, 2022.
Novartis India Q1FY23 PAT jumps to Rs. 52.38 Cr
By IPP Bureau - July 28, 2022
Novartis India has reported total income of Rs. 147.44 crores during the period ended June 30, 2022.
Dr. Reddy's launches Bortezomib for Injection, 3.5 mg Single-Dose Vial in the U.S. Market
By IPP Bureau - July 28, 2022
The Velcade Brand and generic had U.S. sales of approximately $1.2 billion MAT for the most recent twelve months ending in May 2022
India has achieved replacement level fertility: Minister Pawar
By IPP Bureau - July 28, 2022
Pawar also unveiled the India Family Planning 2030 vision document and launched the Medical Eligibility Criteria (MEC) Wheel Application, E-Module of Family Planning Logistics Management System (FPLMIS) and Digital Archive on Family Planning under the category of Digital Intervention.
Velocity Clinical Research begins European expansion with German site acquisition
By IPP Bureau - July 28, 2022
Biopharma and CROs to benefit from simplified access to global research sites
Pfizer and BioNTech advance COVID-19 vaccine strategy with study start of next-generation vaccine candidate
By IPP Bureau - July 28, 2022
This next-generation bivalent COVID-19 vaccine candidate, BNT162b5, consists of RNAs encoding enhanced prefusion spike proteins for the SARS-CoV-2 ancestral strain (wild-type) and an Omicron variant.
Dr Lal Path Labs Q1 FY23 consolidated PAT drops to Rs. 57.7 Cr
By IPP Bureau - July 28, 2022
Dr. Lal Path Labs has reported total income of Rs. 511 crores during the period ended June 30, 2022
Bulk Drug Park in the country :PIB
By IPP Bureau - July 27, 2022
The financial assistance by the centre is subject to a maximum limit of Rs.1000 crore per park
Pharmaceuticals industry under Atmanirbhar Bharat programme
By IPP Bureau - July 27, 2022
India exported about Rs 33,321 crore and imported Rs 35,249 crore worth APIs and Bulk drugs in 2021-22.
Tealium launches customer data platform for pharma
By IPP Bureau - July 27, 2022
Tealium for Pharma utilizes deep integration technology and partnerships to deliver an enhanced customer journey in one of healthcare's most vital sectors
Nuance Pharma announces the completion of dosing for all NTM-001 Phase 1 clinical study
By IPP Bureau - July 27, 2022
The NTM-001 Phase I clinical study is expected to be completed by the end of 2022
Ascentage Pharma and Tanner Pharma Group initiate a global innovative named Patient Program
By IPP Bureau - July 27, 2022
Tanner will be the supplier of olverembatinib to healthcare providers on a named patient basis in countries where the drug is not commercially available.
SKYCovione will strengthen South Korea position in global COVID-19 vaccine industry, says GlobalData
By IPP Bureau - July 27, 2022
This will not only strengthen the country’s overall position in the global vaccine industry but also reduce its reliance on foreign vaccines
